APN 2019 Agenda
| SESSION | TOPIC | SPEAKER | COMPANY | TIME |
| Registration and Breakfast | 7:30AM-8:30AM | |||
| Conference Introductory Comments | Maria Figueiredo | Pfizer | 8:30AM-8:40AM | |
| Opening Plenary Lecture | Biomolecular Biosensors for Health Monitoring and Disease Detection - An Update | Greg Troiano | Seer, Inc. | 8:40AM-9:20AM |
Session I: Particle Technology : Early and Late Stage Technology
Session Chairs: TBA
| SESSION | TOPIC | SPEAKER | COMPANY | TIME |
| Session Introduction | 9:20AM-9:25AM | |||
| A Novel in situ Hydrophobic Ion Paring (HIP) Formulation Strategy for Clinical Product Selection of a Nanoparticle Drug Delivery System | Young-Ho Song | Pfizer | 9:25AM-9:55AM | |
| Promise of Liquid Biopsy for Cancer Management | Hakho Lee | Harvard Medical School | 9:55AM-10:25AM | |
| Break | 10:25AM-10:45AM | |||
| Membrane Vesicles for Vaccine and Therapeutic Delivery | Christopher Locher | Versatope Therapeutics | 10:45AM-11:15AM | |
Session II: Impact of Biology and Immunology in Nanotechnology
Session Chairs: TBA
| SESSION | TOPIC | SPEAKER | COMPANY | TIME |
| Session Introduction | 11:15AM-11:20AM | |||
| Accelerated Blood Clearance of Lipid Nanoparticles Entails a Biphasic Humoral Response of B-1 Followed by B-2 Lymphocyte to Distince Antigenic Moieties | Gilles Besin | Moderna Therapeutics | 11:20AM-11:50AM | |
| Novel Immuno-Modulatory Lipid Nanoparticle Formulations for Vaccines and Immuno-Oncology Applications | Gokul Swaminathan | Merck | 11:50AM-12:20PM | |
| Lunch | 12:20PM-1:35PM | |||
| Understanding Cancer Immune Interactions at the Nanoscale: Going Beyond T cell Immune Checkpoints | Shiladitya Sengupta |
Harvard Medical School/MIT | 1:35PM-2:02PM | |
| Title TBA | Zohreh Amoozgar | Mass General/Harvard Medical School | 2:05PM-2:35PM | |
| Plenary Speaker Introduction | TBA | TBA | 2:35PM-2:40PM | |
| Afternoon Plenary Lecture | Title TBA | Ulrich von Andrian |
Harvard | 2:40PM-3:20PM |
| Break | 3:20PM-3:35PM |
Session III: Regulatory Aspects of Nanotechnology
Sessin Chairs: TBA
| SESSION | TOPIC | SPEAKER | COMPANY | TIME |
| Session Introduction | 3:35PM-3:40PM | |||
| Title TBA | Clarice Hutchens | Pfizer | 3:40PM-4:10PM | |
| Case Studies on CMC and Regulatory Challenges of Liposomal Drug Development | Richard Huang | L.E.A.F. Pharmaceuticals | 4:10PM-4:40PM | |
| Title TBA | Shraddha Thakkar | NCTR/FDA | 4:40PM-5:10PM | |
| Closing Remarks | Maria Figueiredo | Pfizer | 5:10PM-5:15PM | |
| Poster Session and Evening Reception | 5:15PM-6:25PM |